ALZAI Health Corp.

ALZAI is the first AI-driven Alzheimer’s Disease risk screening platform using non-invasive, low-cost, pre-existing biomarker data, providing early detection and improving patient outcomes. ALZAI leverages ubiquitous data from demographics and blood panels present in nearly every adult medical record, applying the ALZAI custom designed suite of AI algorithms.